BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 24909887)

  • 1. Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity.
    Xu HC; Grusdat M; Pandyra AA; Polz R; Huang J; Sharma P; Deenen R; Köhrer K; Rahbar R; Diefenbach A; Gibbert K; Löhning M; Höcker L; Waibler Z; Häussinger D; Mak TW; Ohashi PS; Lang KS; Lang PA
    Immunity; 2014 Jun; 40(6):949-60. PubMed ID: 24909887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1.
    Crouse J; Bedenikovic G; Wiesel M; Ibberson M; Xenarios I; Von Laer D; Kalinke U; Vivier E; Jonjic S; Oxenius A
    Immunity; 2014 Jun; 40(6):961-73. PubMed ID: 24909889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRF9 Prevents CD8
    Huber M; Suprunenko T; Ashhurst T; Marbach F; Raifer H; Wolff S; Strecker T; Viengkhou B; Jung SR; Obermann HL; Bauer S; Xu HC; Lang PA; Tom A; Lang KS; King NJC; Campbell IL; Hofer MJ
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells promote early CD8 T cell responses against cytomegalovirus.
    Robbins SH; Bessou G; Cornillon A; Zucchini N; Rupp B; Ruzsics Z; Sacher T; Tomasello E; Vivier E; Koszinowski UH; Dalod M
    PLoS Pathog; 2007 Aug; 3(8):e123. PubMed ID: 17722980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
    Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections.
    Orange JS; Biron CA
    J Immunol; 1996 Feb; 156(3):1138-42. PubMed ID: 8557990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.
    Zhou S; Cerny AM; Fitzgerald KA; Kurt-Jones EA; Finberg RW
    J Virol; 2012 Oct; 86(20):11254-65. PubMed ID: 22875973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of type I IFN expression by OASL1 permits chronic viral infection and CD8⁺ T-cell exhaustion.
    Lee MS; Park CH; Jeong YH; Kim YJ; Ha SJ
    PLoS Pathog; 2013; 9(7):e1003478. PubMed ID: 23874199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A stay of execution: type I interferons pardon T cells from death by natural killers.
    Kahan SM; Zajac AJ
    Immunity; 2014 Jun; 40(6):861-2. PubMed ID: 24950208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment.
    Gangaplara A; Martens C; Dahlstrom E; Metidji A; Gokhale AS; Glass DD; Lopez-Ocasio M; Baur R; Kanakabandi K; Porcella SF; Shevach EM
    PLoS Pathog; 2018 Apr; 14(4):e1006985. PubMed ID: 29672594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK cells negatively regulate CD8 T cells via natural cytotoxicity receptor (NCR) 1 during LCMV infection.
    Pallmer K; Barnstorf I; Baumann NS; Borsa M; Jonjic S; Oxenius A
    PLoS Pathog; 2019 Apr; 15(4):e1007725. PubMed ID: 30995287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-I IFN drives the differentiation of short-lived effector CD8+ T cells in vivo.
    Wiesel M; Crouse J; Bedenikovic G; Sutherland A; Joller N; Oxenius A
    Eur J Immunol; 2012 Feb; 42(2):320-9. PubMed ID: 22102057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid conversion of effector mechanisms from NK to T cells during virus-induced lysis of allogeneic implants in vivo.
    Brehm MA; Daniels KA; Ortaldo JR; Welsh RM
    J Immunol; 2005 Jun; 174(11):6663-71. PubMed ID: 15905505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progranulin prevents regulatory NK cell cytotoxicity against antiviral T cells.
    Huang A; Shinde PV; Huang J; Senff T; Xu HC; Margotta C; Häussinger D; Willnow TE; Zhang J; Pandyra AA; Timm J; Weggen S; Lang KS; Lang PA
    JCI Insight; 2019 Sep; 4(17):. PubMed ID: 31484831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NK receptor KLRG1 is dispensable for virus-induced NK and CD8+ T-cell differentiation and function in vivo.
    Gründemann C; Schwartzkopff S; Koschella M; Schweier O; Peters C; Voehringer D; Pircher H
    Eur J Immunol; 2010 May; 40(5):1303-14. PubMed ID: 20201037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon.
    Le Bon A; Etchart N; Rossmann C; Ashton M; Hou S; Gewert D; Borrow P; Tough DF
    Nat Immunol; 2003 Oct; 4(10):1009-15. PubMed ID: 14502286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 interferon induction of natural killer cell gamma interferon production for defense during lymphocytic choriomeningitis virus infection.
    Mack EA; Kallal LE; Demers DA; Biron CA
    mBio; 2011; 2(4):. PubMed ID: 21828218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type I IFN substitutes for T cell help during viral infections.
    Wiesel M; Kratky W; Oxenius A
    J Immunol; 2011 Jan; 186(2):754-63. PubMed ID: 21160039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK cells regulate CD8+ T cell priming and dendritic cell migration during influenza A infection by IFN-γ and perforin-dependent mechanisms.
    Ge MQ; Ho AW; Tang Y; Wong KH; Chua BY; Gasser S; Kemeny DM
    J Immunol; 2012 Sep; 189(5):2099-109. PubMed ID: 22869906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.